These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ensuring the safety of genotech drugs through implied warranty theory. Serra WM Am J Law Med; 1997; 23(2-3):363-81. PubMed ID: 9262761 [No Abstract] [Full Text] [Related]
3. A nail in the coffin for DNA sequence patents? Yamanaka M Nat Biotechnol; 2008 Oct; 26(10):1085-6. PubMed ID: 18846072 [No Abstract] [Full Text] [Related]
4. German institutes, industry seek to ease genetic engineering laws. Abbott A Nature; 1992 Sep; 359(6391):93. PubMed ID: 1522906 [No Abstract] [Full Text] [Related]
6. Patent law--claim construction--U.S. District Court for the District of Massachusetts finds conflict on Federal Circuit and holds that product-by-process claims are not limited by their process steps. -- Trustees of Columbia University v. Roche Diagnostics GmbH, 126 F. Supp. 2d 16 (D. Mass. 2000). Harv Law Rev; 2002 Jan; 115(3):923-30. PubMed ID: 11958232 [No Abstract] [Full Text] [Related]
7. Barnyard biotech--lame duck or golden goose? Powell K Nat Biotechnol; 2003 Sep; 21(9):965-7. PubMed ID: 12949546 [No Abstract] [Full Text] [Related]
8. Approval times for supplemental indications for recombinant proteins. Gosse ME; Nelson TF Nat Biotechnol; 1997 Feb; 15(2):130-4. PubMed ID: 9035135 [No Abstract] [Full Text] [Related]
12. Special labeling requirements for genetically engineered food: how sound are the analytical frameworks used by FDA and food producers? Winn LB Food Drug Law J; 1999; 54(4):667-88. PubMed ID: 11824460 [No Abstract] [Full Text] [Related]
13. US food-safety body hears protests over genetically modified food. Macilwain C Nature; 1999 Dec; 402(6762):571. PubMed ID: 10604452 [No Abstract] [Full Text] [Related]